Our top pick for
Building a portfolio

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Inspire Medical Systems, Inc is a medical devices business based in the US. Inspire Medical Systems shares (INSP) are listed on the NYSE and all prices are listed in US Dollars. Inspire Medical Systems employs 341 staff and has a trailing 12-month revenue of around USD$115.4 million.
Our top pick for
Building a portfolio
Our top pick for
Beginners
Our top pick for
Active traders
52-week range | USD$61.04 - USD$252.25 |
---|---|
50-day moving average | USD$213.2512 |
200-day moving average | USD$184.4586 |
Wall St. target price | USD$253.55 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | USD$-1.121 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Revenue TTM | USD$115.4 million |
---|---|
Gross profit TTM | USD$97.8 million |
Return on assets TTM | -15.19% |
Return on equity TTM | -30.96% |
Profit margin | -49.58% |
Book value | $8.487 |
Market capitalisation | USD$5.9 billion |
TTM: trailing 12 months
There are currently 805,177 Inspire Medical Systems shares held short by investors – that's known as Inspire Medical Systems's "short interest". This figure is 2.5% down from 826,110 last month.
There are a few different ways that this level of interest in shorting Inspire Medical Systems shares can be evaluated.
Inspire Medical Systems's "short interest ratio" (SIR) is the quantity of Inspire Medical Systems shares currently shorted divided by the average quantity of Inspire Medical Systems shares traded daily (recently around 270193.62416107). Inspire Medical Systems's SIR currently stands at 2.98. In other words for every 100,000 Inspire Medical Systems shares traded daily on the market, roughly 2980 shares are currently held short.
However Inspire Medical Systems's short interest can also be evaluated against the total number of Inspire Medical Systems shares, or, against the total number of tradable Inspire Medical Systems shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Inspire Medical Systems's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Inspire Medical Systems shares in existence, roughly 30 shares are currently held short) or 0.0331% of the tradable shares (for every 100,000 tradable Inspire Medical Systems shares, roughly 33 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Inspire Medical Systems.
Find out more about how you can short Inspire Medical Systems stock.
We're not expecting Inspire Medical Systems to pay a dividend over the next 12 months.
Over the last 12 months, Inspire Medical Systems's shares have ranged in value from as little as $61.04 up to $252.25. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Inspire Medical Systems's is 1.6275. This would suggest that Inspire Medical Systems's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and Europe. It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. The company also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. Inspire Medical Systems, Inc. was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Steps to owning and managing SGLB, with 24-hour and historical pricing before you buy.
Steps to owning and managing SSD, with 24-hour and historical pricing before you buy.
Steps to owning and managing SQNS, with 24-hour and historical pricing before you buy.
Steps to owning and managing SFL, with 24-hour and historical pricing before you buy.
Steps to owning and managing AIHS, with 24-hour and historical pricing before you buy.
Steps to owning and managing ST, with 24-hour and historical pricing before you buy.
Steps to owning and managing SLCT, with 24-hour and historical pricing before you buy.
Steps to owning and managing EYES, with 24-hour and historical pricing before you buy.
Steps to owning and managing SBSW, with 24-hour and historical pricing before you buy.
Steps to owning and managing SHG, with 24-hour and historical pricing before you buy.